Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

世界のポイントオブケア診断市場動向及び予測(~2018)

◆タイトル:Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
◆商品コード:BT 2328
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年3月
◆ページ数:452
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate licence (社内共有可) USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のポイントオブケア診断市場動向及び予測(~2018)"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の成長要因、阻害要因、産業動向、バリューチェーン分析、サプライチェーン分析、市場環境分析、市場の動態、製品別分析、需要先別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The global POC diagnostics market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil. Factors such as rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are propelling the growth of the POC diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices and the recall of leading glucose monitoring devices are restraining the growth of this market.

In this report, the global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional monitoring kits and patient self-monitoring kits). The glucose monitoring kits market held the largest share—53.7%—of the global POC diagnostics market in 2013, followed by the infectious diseases testing kits market. Factors such as rising global prevalence of diabetes, technological advancements in self-monitoring of blood glucose, and the growing patient awareness toward POC testing are stimulating the growth of the glucose monitoring kits market.

The fastest-growing segment—cardiac-markers market—is projected to grow at a CAGR of 15.3% from 2013 to 2018. This growth is mainly attributed to the increasing number of cardiac patients and the demand of immediate diagnosis of the diseases. Major players such as Roche (Switzerland), Abbott Laboratories, Inc. (U.S.), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), and Alere Inc. (U.S.) are adopting several growth strategies such as new product launches, partnerships, agreements, collaborations, joint ventures, and mergers and acquisition in order to keep pace with the evolving industry trends.

Geographically, North America commands the largest share of the global POC diagnostics market in 2013, followed by Asia-Pacific. A number of factors such as increase in waiver of CLIA for certain point of care diagnostic tests, fostering FDA approvals for various immunoassay techniques, easy access to POC tests through diagnostic service providers, and presence of major leading companies are driving the growth of the POC diagnostics market in North America. However, the economic slowdown and unfavorable reimbursement scenario for tests due to government budget constraints the growth of the POC diagnostics market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as huge patient population base, large number of R&D activities, and growing focus of both international and domestic players on the Asia-Pacific POC diagnostics market are propelling the growth of the dialysis market in the Asia-Pacific region.

The global POC diagnostics market is highly competitive with a large number of global as well as local market players. As of 2012, the global POC diagnostics market excluding the blood glucose monitoring kits market was dominated by Roche (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.), which together accounted for ~72% of the market. New product launches and partnerships/agreements/collaborations/joint ventures are the major strategies adopted by most market players to achieve growth in the POC diagnostics market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (PEST analysis and Porter’s five force model), market share analysis of top players, value chain analysis, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the POC diagnostics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities. The above mentioned market research data, current market size, and forecast of future trends will help existing players and new entrants to make the necessary decisions regarding the product offerings, geographic focus, change in strategic approach, R&D investments for innovation in products and technologies, and levels of output in order to remain successful.

Companies purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping market share.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on POC testing product portfolio offered by the top players in the POC diagnostics market. The report analyzes the products market by category/end user across geographies

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the POC diagnostics market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various POC testing products across geographies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the POC diagnostics market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the POC diagnostics market

【レポートの目次】

Table of Contents

1Introduction (Page No. – 25)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Market Share Estimation
1.6.4 Key Data Points From Secondary Sources
1.6.5 Key Data Points From Primary Sources
1.6.6 Assumptions

2 Executive Summary (Page No. – 37)

3 Premium Insights (Page No. – 42)
3.1 Product Growth Matrix
3.2 Life Cycle Analysis, By Geography
3.3 Market Chasm Analysis

4 Market Overview (Page No. – 47)
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.3.1 Point of Care Diagnostics Market By Product
4.3.2 Point of Care Diagnostics Market By Prescription Mode
4.3.3 Point of Care Diagnostics Market By End User
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Huge prevalence of infectious diseases in developing countries
4.4.1.2 Increasing incidences of lifestyle diseases (cardiac diseases and diabetes)
4.4.1.3 Rising usage of home-based POC devices is improving patient compliance
4.4.1.4 Private investments and venture funding to support development of new products
4.4.1.5 Growing government support to magnify the adoption of POC devices
4.4.1.6 Expansion of therapeutic horizon
4.4.1.7 Fostering approval of novel immunoassay techniques
4.4.1.8 Technological advancements
4.4.1.9 Large number of awareness campaigns/ conferences in developing countries
4.4.1.10 Decreasing number of technicians available in central labs
4.4.2 Restraints
4.4.2.1 Lack of alignment with definitive central lab methods
4.4.2.2 Disadvantages of POC testing over central lab methods
4.4.2.3 Recall of leading glucose monitoring devices
4.4.2.4 Reluctance to change the existing treatment practices
4.4.3 Oppurtunities
4.4.3.1 Emerging markets(India, China, and Brazil)
4.4.3.2 Healthcare decentralization
4.4.3.3 Miniaturization of POC testing devices
4.4.4 Challenges
4.4.4.1 Growing price-cutting measures
4.4.4.2 Stringent and time-consuming regulatory policies
4.4.5 Burning Issues
4.4.5.1 Unfavorable reimbursement scenario in many countries
4.4.5.2 High cost of POC devices
4.4.6 Winning Imperatives
4.4.6.1 Strategy of geographic expansion in emerging markets
4.4.6.2 Strategy of development of low-cost POC devices
4.4.6.3 Strategy of development of multi-assay POC devices

5 Industry Trends (Page No. – 68)
5.1 Introduction
5.2 Value Chain Analysis
5.3 Supply Chain Analysis
5.3.1 Key Influencers:
5.4 Industry Trends
5.4.1 Standardization Of Poc Testing Devices
5.4.2 Acquisition Of Small Players
5.4.3 Growing Focus On Microfluidics-Based Poc Devices
5.4.3.1 Microfluidic technology based lab-on-a-chip devices will bring laboratory testing to patient’s finger tips
5.5 Pricing And Cost Analysis
5.6 Porter’s Five Forces Analysis
5.6.1 Threat From New Entrants
5.6.2 Threat From Substitutes
5.6.3 Bargaining Power Of Suppliers
5.6.4 Bargaining Power Of Buyers
5.6.5 Intensity Of Competitive Rivalry
5.7 PEST Analysis
5.7.1 Political Factors
5.7.2 Economic Factors
5.7.3 Social Factors
5.7.4 Technological Factors
5.8 Strategic Benchmarking
5.8.1 Technology Integration & Product Enhancement
5.8.2 Entry Into Tumor/Cancer Testing Market

6 Point-Of-Care Diagnostics Market, By Product (Page No. – 89)
6.1 Introduction
6.2 Glucose Monitoring Kits Market
6.2.1 Glucose Monitoring Strips Market
6.2.2 Glucose Monitoring Devices Market
6.2.3 Lancets Market
6.3 Cardiac Markers Market
6.4 Infectious Dieases Testing Kits Market
6.4.1 Influenza Testing Kits Market
6.4.2 Hiv Testing Kits Market
6.4.3 Hepatitis b Testing Kits Market
6.4.4 Sexually-Transmitted Diseases (STDS) testing Kits Market
6.4.5 Tuberculosis (TB) Testing Kits Market
6.4.6 Tropical Diseases Testing Kits Market
6.5 Coagulation Monitoring Kits Market
6.5.1 Prothrombin Time (PT/INR) Testing Kits Market
6.5.2 Activated Clotting Time (ACT/APTT) Testing Kits Market
6.6 Pregnancy And Fertility Testing Kits Market
6.6.1 Pregnancy Testing Kits Market
6.6.2 Fertility Testing Kits Market
6.7 Blood Gas/Electrolytes Testing Kits Market
6.8 Tumor/Cancer Markers Market
6.8.1 Urinalysis Testing Kits Market
6.9 Cholesterol Test Strips Market
6.10 Hematology Testing Kits Market
6.10.1 Hemoglobin Assay Kits Market
6.10.2 Hemostasis Assay Kits Market
6.11 Food Pathogens Testing Kits Market
6.12 Drugs Of Abuse Testing Kits Market
6.13 Fecal Occult Testing Kits Market
6.14 Other Testing Kits Market

7 Point-Of-Care Diagnostics Market, By Prescription Mode (Page No. – 143)
7.1 Introduction
7.2 Prescription-Based Testing Kits Market
7.3 Otc Testing Kits Market

8 Point-Of-Care Diagnostics Market, By End User (Page No. – 151)
8.1 Introduction
8.2 Patient Professional Monitoring Kits Market
8.2.1 Inpatient Monitoring Kits Market
8.2.2 Outpatient Monitoring Kits Market
8.2.3 Special Areas Monitoring Kits Market
8.2.4 Other Areas Professional Monitoring Kits Market
8.3 Patient Self-Monitoring Kits Market

9 Point-Of-Care Diagnostics Market, By Geography (Page No. – 163)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest Of Europe (ROE)
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest Of Asia-Pacific
9.5 Rest Of The World (Row)
9.5.1 Latin America
9.5.2 Africa
9.5.3 Middle East

10 Competitive Landscape (Page No. – 307)
10.1 Overview
10.2 Market Share Analysis, Poc Diagnostics Market (Excluding Blood Glucose Monitoring Kits)
10.3 Market Share Analysis, Blood Glucose Monitoring Kits Market
10.4 Competitive Situation And Trends
10.5 New Product Launches
10.6 Agreements, Partnerships, Collaborations, & Joint Ventures
10.7 Mergers And Acquisitions
10.8 Expansions
10.9 Other Developments

11 Company Profiles (Page No. – 342)
11.1 Abaxis, Inc.
11.1.1 Overview
11.1.2 Financials
11.1.3 Products & Services
11.1.4 Strategy
11.1.5 Developments
11.2 Abbott Laboratories, Inc.
11.2.1 Overview
11.2.2 Financials
11.2.3 Products & Services
11.2.4 Strategy
11.2.5 Developments
11.2.6 Swot Analysis
11.2.7 MNM View
11.3 Alere, Inc.
11.3.1 Overview
11.3.2 Financials
11.3.3 Products & Services
11.3.4 Strategy
11.3.5 Developments
11.3.6 Swot Analysis
11.3.7 MnM view
11.4 Bayer Healthcare ag (A Subsidiary Of Bayer ag)
11.4.1 Overview
11.4.2 Financials
11.4.3 Products & Services
11.4.4 Key Strategy
11.4.5 Developments
11.5 Beckman Coulter, Inc. (A Subsidiary Of Danaher Corporation)
11.5.1 Overview
11.5.2 Financials
11.5.3 Products & Services
11.5.4 Strategy
11.5.5 Developments
11.6 Becton, Dickinson And Company
11.6.1 Overview
11.6.2 Financials
11.6.3 Products & Services
11.6.4 Strategy
11.6.5 Developments
11.7 Johnson & Johnson
11.7.1 Overview
11.7.2 Financials
11.7.3 Products & Services
11.7.4 Strategy
11.7.5 Developments
11.8 Nipro Diagnostics, Inc. (A Subsidiary Of Nipro Corporation)
11.8.1 Overview
11.8.2 Financials
11.8.3 Products & Services
11.8.4 Strategy
11.8.5 Developments
11.9 Roche Diagnostics Limited (A Subsidairy Of F. Hoffmann-La Roche Ltd)
11.9.1 Overview
11.9.2 Financials
11.9.3 Products & Services
11.9.4 Strategy
11.9.5 Developments
11.9.6 Swot Analysis
11.9.7 MnM View
11.1 Siemens Healthcare (A Division Of Siemens ag)
11.10.1 Overview
11.10.2 Financials
11.10.3 Products & Services
11.10.4 Strategy
11.10.5 Developments

List Of Tables (198 Tables)

Table 1 Global Point of Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 2 Global Glucose Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 3 Glucose Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 4 Glucose Monitoring Strips Market, By Geography, 2011–2018 ($Million)
Table 5 Glucose Monitoring Devices Market, By Geography, 2011–2018 ($Million)
Table 6 Lancets Market, By Geography, 2011–2018 ($Million)
Table 7 Cardiac Markers Market, By Geography, 2011–2018 ($Million)
Table 8 Global Infectious Diseases Testing Kits Market, By Product, 2011–2018 ($Million)
Table 9 Infectious Diseases Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 10 Influenza Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 11 Hiv Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 12 Hepatitis B Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 13 Stds Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 14 Tb Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 15 Tropical Diseases Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 16 Global Coagulation Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 17 Coagulation Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 18 Prothrombin Time (Pt/Inr) Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 19 Activated Clotting Time (Act/Aptt) Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 20 Global Pregnancy And Fertility Testing Kits Market, By Type, 2011–018 ($Million)
Table 21 Pregnancy And Fertility Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 22 Pregnancy Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 23 Fertility Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 24 Blood Gas/Electrolytes Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 25 Tumor/Cancer Markers Market, By Geography, 2011–2018 ($Million)
Table 26 Urinalysis Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 27 Cholestrol Test Strips Market, By Geography, 2011–2018 ($Million)
Table 28 Global Hematology Testing Kits Market, By Type, 2011–2018 ($Million)
Table 29 Hematology Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 30 Hemoglobin Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 31 Hemostasis Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 32 Food Pathogens Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 33 Drugs Of Abuse Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 34 Fecal Occult Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 35 Other Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 36 Global Point of Care Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 37 Prescription-Based Testing Kits Market, By Geography, 2011–2018 ($Million) 146
Table 38 Otc Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 39 Global Point of Care Diagnostics Market, By End User, 2011–2018 ($Million)
Table 40 Patient Professional Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 41 Inpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 42 Outpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 43 Special Areas Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 44 Other Areas Professional Monitoring Kits Market, By Geography, 2011–2018 ($Million) 160
Table 45 Patient Self-Monitoring Kits Market, By Geography, 2011?–2018 ($Million)
Table 46 Point-Of-Care Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 47 North America: Point-Of-Care Diagnostics Market, By Country, 2011–2018 ($Million)
Table 48 North America: Market, By Product, 2011–2018 ($Million)
Table 49 North America: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 50 North America: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 51 North America: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 52 North America: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 53 North America: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 54 North America: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 55 North America: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 56 North America: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 57 North America: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 58 North America: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 59 North America: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 60 North America: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 61 North America: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 62 North America: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 63 North America: Point-Of-Care Diagnostic Market, By Prescription Mode, 2011–2018 ($Million)
Table 64 North America: Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 65 North America: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 66 North America: Poc Diagnostics Market, By End-User, 2011–2018 ($Million)
Table 67 North America: Patient Self–Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 68 North America: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 69 U.S: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 70 U.S.: Market, By Prescription Mode, 2011–2018 ($Million)
Table 71 U.S.: Market, By End User, 2011–2018 ($Million)
Table 72 Canada: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 73 Canada: Market, By Prescription Mode, 2011–2018 ($Million)
Table 74 Canada: Market, By End User, 2011–2018 ($Million)
Table 75 Mexico: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 76 Mexico: Market, By Prescription Mode, 2011–2018 ($Million)
Table 77 Mexico: Market, By End User, 2011–2018 ($Million)
Table 78 Europe: Point-Of-Care Diagnostics Market, By Country, 2011–2018 ($Million)
Table 79 Europe: Market, By Product, 2011–2018 ($Million)
Table 80 Europe: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 81 Europe: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 82 Europe: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 83 Europe: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 84 Europe: Pregnancy And Fertility Kits Market, By Country, 2011–2018 ($Million)
Table 85 Europe: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 86 Europe: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 87 Europe: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 88 Europe: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 89 Europe: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 90 Europe: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 91 Europe: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 92 Europe: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 93 Europe: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 94 Europe: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 95 Europe: Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 96 Europe: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 97 Europe: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 98 Europe: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 99 Europe: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 100 Germany: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 101 Germany: Market, By Prescription Mode, 2011–2018 ($Million)
Table 102 Germany: Market, By End User, 2011–2018 ($Million)
Table 103 France: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 104 France: Market, By Prescription Mode, 2011–2018 ($Million)
Table 105 France: Point-Of-Care Diagnostics Market, By End User, 2011–2018 ($Million)
Table 106 U.K.: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 107 U.K.: POC Market, By Prescription Mode, 2011–2018 ($Million)
Table 108 U.K.: Market, By End User, 2011–2018 ($Million)
Table 109 Italy: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 110 Italy: POC Market, By Prescription Mode, 2011–2018 ($Million)
Table 111 Italy: Market, By End User, 2011–2018 ($Million)
Table 112 Spain: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 113 Spain: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 114 Spain: Market, By End User, 2011–2018 ($Million)
Table 115 ROE: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 116 ROE: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 117 ROE: Market, By End User, 2011–2018 ($Million)
Table 118 Asia-Pacific: Point-Of-Care Diagnostics Market, By Country, 2011–2018 ($Million)
Table 119 Asia-Pacific: Market, By Product, 2011–2018 ($Million)
Table 120 Asia-Pacific: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 121 Asia-Pacific: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 122 Asia-Pacific: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 123 Asia-Pacific: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 124 Asia-Pacific: Pregnancy And Fertility Kits Market, By Country, 2011–2018 ($Million)
Table 125 Asia-Pacific: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 126 Asia-Pacific: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 127 Asia-Pacific: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 128 Asia-Pacific: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 129 Asia-Pacific: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 130 Asia-Pacific: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 131 Asia-Pacific: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 132 Asia-Pacific: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 133 Asia-Pacific: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 134 Asia-Pacific: Point-Of-Care Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 135 Asia-Pacific : Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 136 Asia-Pacific: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 137 Asia-Pacific: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 138 Asia-Pacific: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 139 Asia-Pacific: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 140 Japan: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 141 Japan: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 142 Japan: Market, By End User, 2011–2018 ($Million)
Table 143 China: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 144 China: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 145 China: Market, By End User, 2011–2018 ($Million)
Table 146 India: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 147 India: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 148 India: Market, By End User, 2011–2018 ($Million)
Table 149 ROAa: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 150 ROA: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 151 ROA: Market, By End User, 2011 – 2018 ($Million)
Table 152 ROW: Point-Of-Care Diagnostics Market, By Region, 2011–2018 ($Million)
Table 153 ROW: Market, By Product, 2011–2018 ($Million)
Table 154 ROW: Glucose Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 155 ROW: Cardiac Markers Market, By Region, 2011–2018 ($Million)
Table 156 ROW: Infectious Diseases Testing Kits Market, By Region, 2011–2018 ($Million)
Table 157 ROW: Coagulation Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 158 ROW: Pregnancy And Fertility Kits Market, By Region, 2011–2018 ($Million)
Table 159 ROW: Blood Gas And Electrolytes Testing Kits Market, By Region, 2011–2018 ($Million)
Table 160 ROW: Tumor/Cancer Markers Market, By Region, 2011–2018 ($Million)
Table 161 ROW: Urinalysis Testing Kits Market, By Region, 2011–2018 ($Million)
Table 162 ROW: Cholestrol Test Strips Market, By Region, 2011–2018 ($Million)
Table 163 ROW: Hematology Testing Kits Market, By Region, 2011–2018 ($Million)
Table 164 ROW: Food Pathogens Testing Kits Market, By Region, 2011–2018 ($Million)
Table 165 ROW: Drugs Of Abuse Testing Kits Market, By Region, 2011–2018 ($Million)
Table 166 ROW: Fecal Occult Testing Kits Market, By Region, 2011–2018 ($Million)
Table 167 ROW: Other Testing Kits Market, By Region, 2011–2018 ($Million)
Table 168 ROW: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 169 ROW: Otc Testing Kits Market, By Region, 2011–2018 ($Million)
Table 170 ROW: Prescription-Based Testing Kits Market, By Region, 2011–2018 ($Million)
Table 171 ROW: Poc Diagnostics Market, By Enduser, 2011–2018 ($Million)
Table 172 ROW: Patient Self-Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 173 ROW: Professional Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 174 Latin America: Point-Of-Care Diagnostics Market, By Product, 2011 – 2018 ($Million)
Table 175 Latin America: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 176 Latin America: tics Market, By End User, 2011–2018 ($Million)
Table 177 Africa: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 178 Africa: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 179 Africa: Market, By End User, 2011–2018 ($Million)
Table 180 Middle East: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 181 Middle East: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 182 Middle East: Market, By End User, 2011–2018 ($Million)
Table 183 New Product Launches, 2011–2014
Table 184 Agreements, Partnerships, Collaborations, And Joint Ventures, 2011–2014
Table 185 Mergers And Acquisitions, 2011–2014
Table 186 Expansion, 2011–2014
Table 187 Other Developments, 2011 – 2014
Table 188 Abaxis, Inc.: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 189 Abbott Laboratories, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 190 Alere, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 191 Bayer Ag: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 192 Danaher Corporation: Total Revenue, 2010–2012 ($Million)
Table 193 Danaher Corporation: Total Revenue, By Segment, 2010–2012 ($Million)
Table 194 Becton, Dickinson And Company: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 195 Johnson & Johnson: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 196 Nipro Corporation: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 197 Roche Diagnostics Limited: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 198 Siemens Healthcare: Total Revenue And R&D Expenditure, 2011–2013 ($Million)

List of Figures (50 Figures)

FIGURE 1 GLOBAL POC DIAGNOSTICS MARKET: RESEARCH METHODOLOGY
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 3 GLOBAL POC DIAGNOSTICS MARKET, BY PRODUCT, 2013
FIGURE 4 GLOBAL POC DIAGNOSTICS MARKET, BY GEOGRAPHY, 2013
FIGURE 5 POC DIAGNOSTICS MARKET: PRODUCT GROWTH MATRIX
FIGURE 6 POC DIAGNOSTICS MARKET LIFE CYCLE ANALYSIS: BY GEOGRAPHY
FIGURE 7 POC DIAGNOSTICS MARKET: CHASM ANALYSIS
FIGURE 8 EVOLUTION OF POC TESTING
FIGURE 9 POC DIAGNOSTICS MARKET: BY PRODUCT
FIGURE 10 POC DIAGNOSTICS MARKET: BY PRESCRIPTION MODE
FIGURE 11 POC DIAGNOSTICS MARKET: BY END USER
FIGURE 12 MARKET DYNAMICS: GLOBAL POC DIAGNOSTICS MARKET
FIGURE 13 VALUE CHAIN ANALYSIS: POC DIAGNOSTICS MARKET
FIGURE 14 POC DIAGNOSTICS MARKET: SUPPLY CHAIN
FIGURE 15 PRICING TREND: POC DEVICES, 2013–2018
FIGURE 16 PORTER’S FIVE FORCES ANALYSIS: GLOBAL POC DIAGNOSTICS MARKET, 2013
FIGURE 17 POC DIAGNOSTICS MARKET: PEST ANALYSIS, 2013
FIGURE 18 STRATEGIC BENCHMARKING: TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT
FIGURE 19 STRATEGIC BENCHMARKING: ENTRY INTO TUMOR/CANCER TESTING MARKET
FIGURE 20 GLOBAL POC DIAGNOSTICS (EXCLUDING BLOOD GLUCOSE MONITORING KITS) MARKET SHARE, BY KEY PLAYER, 2012
FIGURE 21 GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SHARE, BY KEY PLAYER, 2012
FIGURE 22 KEY GROWTH STRATEGIES, 2011–2014
FIGURE 23 ABAXIS, INC.: TOTAL REVENUE, BY SEGMENT, 2013
FIGURE 24 ABAXIS, INC.: TOTAL REVENUE, BY PRODUCT AND SERVICE CATEGORY, 2013
FIGURE 25 ABAXIS, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2013
FIGURE 26 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENT, 2012
FIGURE 27 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2012
FIGURE 28 ABBOTT LABORATORIES, INC.: MARKET STRATEGY, 2011–2013
FIGURE 29 ALERE, INC.: TOTAL REVENUE, BY SEGMENTS, 2012
FIGURE 30 ALERE, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2012
FIGURE 31 ALERE, INC.: MARKET STRATEGY, 2011–2013
FIGURE 32 BAYER AG: TOTAL REVENUE, BY SEGMENT, 2012
FIGURE 33 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, 2012
FIGURE 34 DANAHER CORPORATION: LIFE SCIENCES AND DIAGNOSTICS SEGMENT REVENUE MIX, 2012
FIGURE 35 DANAHER CORPORATION: LIFE SCIENCES & DIAGNOSTICS SEGMENT REVENUE, BY GEOGRAPHY, 2012
FIGURE 36 BECKMAN COULTER, INC.: MAJOR STRATGY, 2011–2014
FIGURE 37 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, 2013
FIGURE 38 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, 2013
FIGURE 39 BECTON, DICKINSON AND COMPANY: MARKET STRATEGY, 2011–2014
FIGURE 40 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENT, 2012
FIGURE 41 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2012
FIGURE 42 JOHNSON & JOHNSON: DIAGNOSTICS FRANCHISE REVENUE, 2010–2012 ($MILLION)
FIGURE 43 JOHNSON & JOHNSON: MARKET STRATEGY, 2011–2013
FIGURE 44 NIPRO CORPORATION: TOTAL REVENUE, BY SEGMENT, 2013
FIGURE 45 NIPRO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2013
FIGURE 46 ROCHE DIAGNOSTICS LIMITED: TOTAL REVENUE, BY SEGMENT, 2013
FIGURE 47 ROCHE DIAGNOSTICS LIMITED: TOTAL REVENUE, BY GEOGRAPHY, 2013
FIGURE 48 ROCHE DIAGNOSTICS LIMITED: MARKET STRATEGY, 2011–2013
FIGURE 49 SIEMENS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2013
FIGURE 50 SIEMENS HEALTHCARE: MARKET STRATEGY, 2011–2013


★調査レポート[世界のポイントオブケア診断市場動向及び予測(~2018)] ( Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018 / BT 2328) 販売に関する免責事項
[世界のポイントオブケア診断市場動向及び予測(~2018)] ( Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018 / BT 2328) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆